Free Trial
→ Last call for your free 0DTE report (From Profits Run) (Ad)tc pixel
NASDAQ:TWST

Twist Bioscience Q4 2026 Earnings Date & Estimates

Twist Bioscience logo
$129.04 -23.74 (-15.54%)
Closing price 04:00 PM Eastern
Extended Trading
$128.80 -0.23 (-0.18%)
As of 07:21 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Twist Bioscience is estimated to report Q4 2026 earnings on Thursday, November 12, 2026, before market opens. The conference call is scheduled for 8:00 AM ET.

Research:ProfileEarnings HistoryForecast

Upcoming Earnings Announcement

Quarter
Q4 2026
Announcement Date
Time
Before Market Opens
Conference Call
8:00 AM ET
Google Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab)

What Analysts Expect from Twist Bioscience in Q4 2026

Twist Bioscience is expected to post earnings of -$0.3845 per share on revenue of $123.59 million. In the same quarter a year earlier Twist Bioscience reported -$0.45 per share on revenue of $99.01 million. Twist Bioscience last reported on August 3, 2026, posting -$0.56 per share and missing the -$0.5063 consensus estimate. Twist Bioscience has beaten the consensus EPS estimate in 2 of its last 8 quarters.

Consensus Estimates

Consensus EPS
-$0.3845
Expected Revenue
$123.59 million
Prior-Year EPS
-$0.45
Prior-Year Revenue
$99.01 million
Expected Revenue Growth
+24.8%

Recent Track Record

Last Reported
Q3 2026
Last Quarter EPS
-$0.56 (Missed by -$0.0538)
Last Quarter Revenue
$118.38 million
EPS Beat Rate
2 of last 8 quarters

Prepare for the Q4 2026 Call

Twist Bioscience Q4 2026 Earnings FAQ

Twist Bioscience (NASDAQ:TWST) is estimated to report Q4 2026 earnings on Thursday, November 12, 2026, before market opens. This date is estimated from past reporting schedules and may change once the company confirms it.

Twist Bioscience's Q4 2026 earnings conference call is scheduled for Thursday, November 12, 2026 at 8:00 AM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date.

Analysts expect Twist Bioscience to post earnings of -$0.3845 per share for Q4 2026.

The consensus revenue estimate for Twist Bioscience is $123.59 million for Q4 2026.

Twist Bioscience Earnings Headlines

Twist Bioscience (NASDAQ:TWST) Stock Price Down 11.6% - What's Next?
November 1 at 4:32 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31172268
Robust Demand Across BioPharma and NGS Applications Elevates Twist Bioscience Corp.’s (TWST) Growth Profile
October 29, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/robust-demand-across-biopharma-ngs-151546343.html
Last call for your free 0DTE report
The 0DTE Game Plan lays out a simple 3-step framework for trading same-day options: Plan it, profit from it, protect it. This report normally sells for 29.97, but it's available as a free download for a limited time.tc pixel
November 2 at 1:00 AM  |  Profits Run (Ad)
Twist Bioscience Stock Gains Attention After Antibody Screening Launch
October 29, 2026  |  uk.finance.yahoo.comhttps://uk.finance.yahoo.com/news/twist-bioscience-stock-gains-attention-071726615.html
Twist Bioscience Soars 12%, 10x Genomics Up 12% as Genomics Stocks Rebound
October 28, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/twist-bioscience-soars-12-10x-183451735.html
Twist Bioscience Expands High-Throughput Antibody Characterization with Launch of Express Screening Antibodies
October 28, 2026  |  marketscreener.comM
See More Twist Bioscience Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Twist Bioscience? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Twist Bioscience and other key companies, straight to your email.

About Twist Bioscience

Twist Bioscience (NASDAQ:TWST) is a biotechnology company that develops and manufactures synthetic DNA and related products for life sciences research. The company uses a proprietary silicon-based platform to produce high-quality DNA at scale, supporting applications in synthetic biology, drug discovery and development, agriculture, and academic and industrial research.

Its offerings include synthetic genes, oligonucleotides, gene fragments, variant libraries, and antibody discovery products. Twist also provides next-generation sequencing preparation solutions, including target-enrichment panels and other tools designed to help researchers analyze genetic material. These products are used by pharmaceutical and biotechnology companies, academic institutions, and other research organizations.

Founded in 2013 and headquartered in South San Francisco, California, Twist Bioscience serves customers in the United States and international markets. The company was founded by Emily M. Leproust, who serves as its chief executive officer and has led the business since its early development.

View Twist Bioscience Profile
Earnings Tools